| Description |
1 online resource (xii, 297 pages) : illustrations |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
| Series |
Clinical challenges |
|
Clinical challenges.
|
| Bibliography |
Includes bibliographical references and index. |
| Contents |
7. Metabolism of apolipoprotein B-100-containing lipoproteins in dyslipidaemias8. Sex-specific aspects of dyslipidaemia and atherosclerosis; Part III: Prevention and treatment strategies; 9. New clinical trials oflipid-regulating agents; 10. Genetics of dyslipidaemia andcoronary risk (personalized lipid-lowering treatment); 11. Application of proteomic, metabolomic and lipidomic approaches to coronary heart disease risk prediction; 12. N. |
| Summary |
Lipid disorders are highly heterogeneous and widely prevalent throughout the world. Dyslipidemia is an important risk factor for atherosclerotic disease and its clinical sequelae, including myocardial infarction, ischemic stroke, and death. The impact of dyslipidemia treatment on risk for cardiovascular disease is one of the most intensively studied issues in all of medicine. This volume is an innovative approach to the identification and management of lipid disorders. Organized as a series of questions, each chapter presents a detailed yet accessible discussion of the problems posed. The ques. |
| Note |
Print version record. |
| Subject |
Lipids -- Metabolism -- Disorders.
|
|
Dyslipidemias -- diagnosis |
|
Dyslipidemias -- therapy |
|
MEDICAL -- Endocrinology & Metabolism.
|
|
MEDICAL -- Nutrition.
|
|
Lipids -- Metabolism -- Disorders
|
| Added Author |
Sica, Domenic A.
|
| Other Form: |
Print version: Clinical challenges in lipid disorders. Oxford ; Ashland, OH : Clinical Pub., 2008 9781846920295 (OCoLC)174130919 |
| ISBN |
9781846925917 (electronic bk.) |
|
1846925916 (electronic bk.) |
|
9781846920295 |
|
1846920299 |
| Standard No. |
CDX 9001669 |
|
AU@ 000051355809 |
|
AU@ 000058023281 |
|
DEBBG BV043154773 |
|
DEBSZ 422078840 |
|
GBVCP 802709303 |
|
